Advertisement

Direct Patient Education Helps Limit Benzodiazepine Use Among Elders — Physician’s First Watch

Medical News |
April 15, 2014

Direct Patient Education Helps Limit Benzodiazepine Use Among Elders

By Amy Orciari Herman

Older adults often choose to stop using benzodiazepines when they're educated about the drugs' risks and offered a tapering schedule, a JAMA Internal Medicine study finds.

Some 30 Montreal-based pharmacies were randomized to provide a patient-education intervention to older, long-term benzodiazepine users or to provide usual care. In the intervention group, patients were mailed a booklet that included information on benzodiazepines' risks, suggestions for alternative treatments for insomnia or anxiety, tapering recommendations, and instructions to talk with their physician or pharmacist about discontinuing use.

Roughly 300 adults aged 65 and older were included in the study. At 6 months, nearly two thirds of intervention patients had initiated discussions about benzodiazepine discontinuation with their physician or pharmacist. In addition, significantly more intervention than usual-care patients had discontinued using the drugs (27% vs. 5%), with four people needing to receive the intervention for one person to discontinue benzodiazepine use.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement